Related Experiment Video
Updated: Apr 17, 2026

Murine Colitis Modeling using Dextran Sulfate Sodium DSS
Published on: January 19, 2010
Localized Rectal Dextran Sulfate Sodium-Induced Colitis Is Associated with Small-Intestinal Shortening and Gut-Liver
Masahiko Mori1, Makoto Ishii1, Ruri Nakagawa1
1Department of Drug Absorption and Pharmacokinetics, Faculty of Pharmacy, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan.
Researchers developed a new rectal dextran sulfate sodium (DSS) model for ulcerative colitis (UC) in rats. This localized method minimizes systemic exposure, offering a better approach for studying colon inflammation and its effects on other organs.
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease Research
- Animal Models of Disease
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease affecting the colon.
- Existing dextran sulfate sodium (DSS)-induced UC models often use oral administration, leading to widespread exposure and complicating extracolonic organ assessment.
- A need exists for a localized UC model to better study colon-specific inflammation and its systemic impact.
Purpose of the Study:
- To establish a localized ulcerative colitis (UC) model in rats via rectal administration of dextran sulfate sodium (DSS).
- To evaluate if this rectal DSS approach reduces direct DSS exposure to the small intestine and liver compared to oral models.
- To assess the impact of this localized inflammation on small intestinal morphology, hepatobiliary function, and the efficacy of 5-aminosalicylic acid treatment.
Main Methods:
- Rats were administered 40% DSS rectally for 13 days.
- Monitoring included body weight, Disease Activity Index (DAI), and histological scoring.
- Evaluated small intestinal morphology, inflammatory markers, bile flow, and hepatic bile salt export pump mRNA levels.
- Assessed the effects of 5-aminosalicylic acid treatment.
Main Results:
- Rectal DSS successfully induced localized distal colon and rectal inflammation, mirroring UC features like weight loss and mucosal injury.
- 5-aminosalicylic acid partially alleviated some DSS-induced effects.
- The small intestine showed shortening without inflammatory cell infiltration or increased cytokines.
- DSS treatment led to decreased bile flow and hepatic bile salt export pump expression, indicating hepatobiliary dysfunction.
Conclusions:
- The rectal DSS administration model provides a controlled and reproducible method for inducing colon-specific inflammation.
- This localized model overcomes limitations of oral DSS models, facilitating extracolonic organ evaluation.
- The model serves as a valuable research basis for studying inter-organ interactions, gut-liver axis dysfunction, and drug absorption in UC.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Ulcerative Colitis in IBD

